Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Postexposure prophylaxis using artemisinin-based combination therapy (ACT) was prescribed to a malaria-naive nurse who experienced an injury with a hollow needle previously used on a patient admitted for severe imported
Plasmodium falciparum
malaria (blood parasitemia 10.8%).
Artemether
-lumefantrine, four tablets twice daily for 3 days, was started 12 hours after exposure, and no side effects were reported. During the six following months, she only developed one episode of fever that was associated with
pyelonephritis
. Biological follow-up, based on blood smears, molecular biology, and serology, did not evidence
P. falciparum
malaria. This case suggests that ACT can prevent occupational
P. falciparum
malaria following needle-stick injury. We found evidence of only one other unpublished similar case where a Turkish resident doctor did not develop malaria after postexposure prophylaxis using ACT. Such a prophylaxis could be prescribed not only in case of occupational exposure to
Plasmodium
spp. in nonvector-borne laboratory-acquired infections but also following blood exposure in healthcare setting.
...
PMID:Case Report: Could Artemisinin-Based Combination Therapy Prevent Occupational Malaria following Blood Exposure? 3323 1